Department of Medicine
-
March 30, 2023
New treatment helps mitigate hair loss for chemotherapy patients
Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens. -
March 30, 2023
One Hundred Oaks COVID-19 vaccination site to close April 7
The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7. -
March 30, 2023
VUMC researcher selected for Global Scholars Program
Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 Novartis Institutes for BioMedical Research Global Scholars Program. -
March 28, 2023
Inflammation implicated in exfoliation syndrome
Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness. -
March 23, 2023
Saunders receives diabetes research innovation award
Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes. -
March 16, 2023
Study evaluates polygenic risk score for prostate cancer risk prediction
A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening. -
March 16, 2023
Eng stresses need for clinical trial support at cancer forum
Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.